VAERS 1548367
MODERNA · COVID19 (COVID19 (MODERNA)) · Charge U31620A
- Staat
- FL
- Alter
- 69,0
- Geschlecht
- F
- Eingang
- 12.08.2021
- Impfdatum
- 09.02.2021
- Beginn
- 09.02.2021
- Tage bis Beginn
- 0,0
- Dosis
- 2
- Route/Site
- OT / LA
Symptomtext
hot; tchy; red spot, size 2 coins; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of VACCINATION SITE WARMTH (hot), VACCINATION SITE PRURITUS (tchy) and VACCINATION SITE ERYTHEMA (red spot, size 2 coins) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. U31620A) for COVID-19 vaccination. The patient's past medical history included No adverse event (No medical history reported). On 09-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) Dose 2. On 09-Feb-2021, the patient experienced VACCINATION SITE WARMTH (hot), VACCINATION SITE PRURITUS (tchy) and VACCINATION SITE ERYTHEMA (red spot, size 2 coins). At the time of the report, VACCINATION SITE WARMTH (hot), VACCINATION SITE PRURITUS (tchy) and VACCINATION SITE ERYTHEMA (red spot, size 2 coins) had not resolved. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) and mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. Treatment includes Benadryl. Most recent FOLLOW-UP information incorporated above includes: On 25-May-2021: No specific follow-up information recorded.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Vaccination site pruritus
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- Medical History/Concurrent Conditions: No adverse event (No medical history reported)
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -